Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein

被引:53
作者
Lu, J [1 ]
Zhi, N [1 ]
Wong, S [1 ]
Brown, KE [1 ]
机构
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1086/499599
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Parvovirus B19 infection in adults is often associated with acute symmetrical polyarthropathy, but the mechanism is unknown. Recently, a secreted phospholipase A 2 ( sPLA 2) motif was identified in the VP1- unique region ( VP1u) of the B19 minor capsid protein. To investigate the role of this motif, we expressed VP1u with and without point mutations in the critical amino acids of sPLA(2). Although high concentrations of B19 did not infect human fibroblast - like synoviocytes ( HFLSs), there was a > 3-fold increase in synoviocyte migration that could be blocked by phospholipase inhibitors. Recombinant proteins with intact VP1u demonstrated sPLA 2 activity and induced cell migration, whereas proteins with mutated VP1u were nonfunctional in both assays. The incubation of HFLSs with proteins that had intact VP1u, but not with proteins with mutated VP1u, increased the production of prostaglandin E-2 > 100-fold. Expression of cyclooxygenase ( COX) - 2 mRNA transcripts, as determined by real-time reverse-transcription polymerase chain reaction, and COX-2 protein expression were both significantly increased after incubation with protein that had intact VP1u. Proteins with VP1u in noninfectious B19 may participate in the inflammatory response in the synovial compartment.
引用
收藏
页码:582 / 590
页数:9
相关论文
共 63 条
  • [1] THE STRUCTURE OF HUMAN PARVOVIRUS-B19 AT 8-ANGSTROM RESOLUTION
    AGBANDJE, M
    KAJIGAYA, S
    MCKENNA, R
    YOUNG, NS
    ROSSMANN, MG
    [J]. VIROLOGY, 1994, 203 (01) : 106 - 115
  • [2] ANDERSON MJ, 1983, LANCET, V1, P1378
  • [3] EXPERIMENTAL PARVOVIRAL INFECTION IN HUMANS
    ANDERSON, MJ
    HIGGINS, PG
    DAVIS, LR
    WILLMAN, JS
    JONES, SE
    KIDD, IM
    PATTISON, JR
    TYRRELL, DAJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) : 257 - 265
  • [4] ERYTHEMA INFECTIOSUM (FIFTH DISEASE) - CLINICAL REVIEW AND DESCRIPTION OF 91 CASES SEEN IN AN EPIDEMIC
    BALFOUR, HH
    [J]. CLINICAL PEDIATRICS, 1969, 8 (12) : 721 - +
  • [5] BERNS KI, 2000, VIRUS TAXONOMY CLASS, P169
  • [6] Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes
    Bidgood, MJ
    Jamal, OS
    Cunningham, AM
    Brooks, PM
    Scott, KF
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (05) : 2790 - 2797
  • [7] WHAT THREAT IS HUMAN PARVOVIRUS-B19 TO THE FETUS - A REVIEW
    BROWN, KE
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (07): : 764 - 767
  • [8] BROWN T, 1984, LANCET, V2, P1033
  • [9] Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor
    Buchanan, FG
    Wang, DZ
    Bargiacchi, F
    DuBois, RN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) : 35451 - 35457
  • [10] Interfacial enzymology of parvovirus phospholipases A2
    Canaan, S
    Zádori, Z
    Ghomashchi, F
    Bollinger, J
    Sadilek, M
    Moreau, ME
    Tijssen, P
    Gelb, MH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) : 14502 - 14508